Replies to post #111550 on Biotech Values

[genisi]

And this trial of AstraZeneca's anti-NGF candidate, MEDI-578, in patients with osteoarthritis of the knee, has been terminated:

http://clinicaltrials.gov/ct2/show/NCT01072591